Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI
Status:
Withdrawn
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of Ticagrelor versus Clopidogrel for the reduction of
adverse cardiovascular outcomes in patients with high platelet reactivity on clopidogrel
after successful implantation of coronary drug-eluting stents.
Phase:
Phase 3
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University